Related Experiment Video
Updated: Sep 6, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
MIR503HG impeded ovarian cancer progression by interacting with SPI1 and preventing TMEFF1 transcription
Jun Tian1, Lei Yang2, Zhongtai Wang3
1Department Gynecology, HuaiHe Hospital of HeNan University, Kaifeng, HeNan, China.
Abstract:
MIR503 host gene (MIR503HG) acts as an important tumor suppressor in many human cancers, but its role and regulatory mechanism in ovarian cancer need to be further studied. In this study, lower expressed MIR503HG was observed in ovarian tumor tissues and cells than in adjacent normal tissues and normal human ovarian epithelial cells. MIR503HG overexpression impaired the proliferative, invasive and EMT properties, and facilitated cell apoptosis in ovarian cancer cells. Nuclear and cytoplasmic separation test suggested that MIR503HG was mainly expressed in the nucleus. RNA immunoprecipitation and RNA pull-down assays confirmed that MIR503HG could bind to transcription factor SPI1 (Spi-1 proto-oncogene), and dual luciferase reporter gene and Chromatin immunoprecipitation assays verified that SPI1 could bind to TMEFF1 (Transmembrane protein with EGF like and two follistatin like domains 1) promoter, suggesting that MIR503HG suppressed TMEFF1 expression by competitively binding SPI1 and blocking transcriptional activation of TMEFF1. Moreover, interference with TMEFF1 reversed the promotion effect of MIR503HG silence on the malignant behaviors of ovarian cancer cells. Moreover, MIR503HG knockdown activated the MAPK and PI3K/AKT pathways by increasing the expression of TMEFF1. In addition, overexpression of MIR503HG in vivo suppressed the tumorigenic ability in nude mice. In conclusion, MIR503HG acted as a tumor suppressor lncRNA in ovarian cancer by suppressing transcription factor SPI1-mediated transcriptional activation of TMEFF1.
Insights
MIR503 host gene (MIR503HG) suppresses ovarian cancer progression by inhibiting SPI1-mediated TMEFF1 activation. Overexpression of MIR503HG reduces proliferation and invasion, while its silencing promotes these malignant behaviors.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- The MIR503 host gene (MIR503HG) is recognized as a tumor suppressor in various human cancers.
- Its specific function and regulatory mechanisms in ovarian cancer remain incompletely understood.
Purpose of the Study:
- To investigate the role of MIR503HG in ovarian cancer.
- To elucidate the molecular mechanisms underlying MIR503HG's function in ovarian cancer.
Main Methods:
- Quantitative real-time PCR to assess MIR503HG expression levels.
- Cell proliferation, invasion, apoptosis, and EMT assays to evaluate MIR503HG function.
- RNA immunoprecipitation, RNA pull-down, dual luciferase reporter, and Chromatin immunoprecipitation assays to determine molecular interactions.
- Western blotting to analyze pathway activation.
- In vivo tumorigenesis assays in nude mice.
Main Results:
- MIR503HG expression was significantly lower in ovarian tumor tissues and cells compared to normal controls.
- MIR503HG overexpression inhibited ovarian cancer cell proliferation, invasion, and epithelial-mesenchymal transition (EMT), while promoting apoptosis.
- MIR503HG directly binds to transcription factor SPI1, inhibiting SPI1-mediated transcriptional activation of TMEFF1.
- MIR503HG knockdown led to increased TMEFF1 expression, activating MAPK and PI3K/AKT pathways.
- MIR503HG overexpression suppressed tumor growth in vivo.
Conclusions:
- MIR503HG functions as a tumor suppressor long non-coding RNA (lncRNA) in ovarian cancer.
- MIR503HG exerts its tumor-suppressive effects by inhibiting the SPI1-TMEFF1 axis.
- MIR503HG represents a potential therapeutic target for ovarian cancer treatment.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Gene Regulation During Sporulation
Mitogens and the Cell Cycle

